Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 09    symbols : Axsm    save search
Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics
Published: 2022-05-09 (Crawled : 12:00) - biospace.com/
JAZZ | $109.96 0.63% 0.63% 760K twitter stocktwits trandingview |
Health Technology
 | | O: -1.4% H: 0.61% C: -4.73%
AXSM | $67.91 3.33% 3.22% 890K twitter stocktwits trandingview |
Health Technology
 | | O: -17.99% H: 1.48% C: -7.64%
sunosi therapeutics solriamfetol
Axsome Therapeutics Completes U.S. Acquisition of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
Published: 2022-05-09 (Crawled : 12:00) - prnewswire.com
JAZZ | $109.96 0.63% 0.63% 760K twitter stocktwits trandingview |
Health Technology
 | | O: -1.4% H: 0.61% C: -4.73%
AXSM | $67.91 3.33% 3.22% 890K twitter stocktwits trandingview |
Health Technology
 | | O: -17.99% H: 1.48% C: -7.64%
sunosi acquisition narcolepsy therapeutics solriamfetol
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.